Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1952 1
1953 1
1955 1
1956 1
1957 6
1958 4
1959 2
1960 2
1961 1
1962 2
1963 2
1965 3
1966 1
1967 1
1968 1
1969 1
1971 2
1972 1
1973 3
1974 2
1975 2
1976 2
1977 1
1978 3
1979 2
1980 1
1981 3
1982 2
1983 6
1984 6
1985 11
1986 10
1987 15
1988 9
1989 12
1990 15
1991 12
1992 30
1993 28
1994 28
1995 24
1996 44
1997 41
1998 52
1999 44
2000 52
2001 75
2002 61
2003 94
2004 98
2005 105
2006 127
2007 130
2008 157
2009 232
2010 280
2011 280
2012 307
2013 321
2014 374
2015 395
2016 443
2017 523
2018 565
2019 625
2020 766
2021 901
2022 937
2023 924
2024 843
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,067 results

Results by year

Filters applied: . Clear all
Page 1
Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.
Ramli MNB, Lim YS, Koe CT, Demircioglu D, Tng W, Gonzales KAU, Tan CP, Szczerbinska I, Liang H, Soe EL, Lu Z, Ariyachet C, Yu KM, Koh SH, Yaw LP, Jumat NHB, Lim JSY, Wright G, Shabbir A, Dan YY, Ng HH, Chan YS. Ramli MNB, et al. Among authors: yu km. Gastroenterology. 2020 Oct;159(4):1471-1486.e12. doi: 10.1053/j.gastro.2020.06.010. Epub 2020 Jun 15. Gastroenterology. 2020. PMID: 32553762 Free article.
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.
Skokos D, Waite JC, Haber L, Crawford A, Hermann A, Ullman E, Slim R, Godin S, Ajithdoss D, Ye X, Wang B, Wu Q, Ramos I, Pawashe A, Canova L, Vazzana K, Ram P, Herlihy E, Ahmed H, Oswald E, Golubov J, Poon P, Havel L, Chiu D, Lazo M, Provoncha K, Yu K, Kim J, Warsaw JJ, Stokes Oristian N, Siao CJ, Dudgeon D, Huang T, Potocky T, Martin J, MacDonald D, Oyejide A, Rafique A, Poueymirou W, Kirshner JR, Smith E, Olson W, Lin J, Thurston G, Sleeman MA, Murphy AJ, Yancopoulos GD. Skokos D, et al. Among authors: yu k. Sci Transl Med. 2020 Jan 8;12(525):eaaw7888. doi: 10.1126/scitranslmed.aaw7888. Sci Transl Med. 2020. PMID: 31915305
Single-cell atlas of the human brain vasculature across development, adulthood and disease.
Wälchli T, Ghobrial M, Schwab M, Takada S, Zhong H, Suntharalingham S, Vetiska S, Gonzalez DR, Wu R, Rehrauer H, Dinesh A, Yu K, Chen ELY, Bisschop J, Farnhammer F, Mansur A, Kalucka J, Tirosh I, Regli L, Schaller K, Frei K, Ketela T, Bernstein M, Kongkham P, Carmeliet P, Valiante T, Dirks PB, Suva ML, Zadeh G, Tabar V, Schlapbach R, Jackson HW, De Bock K, Fish JE, Monnier PP, Bader GD, Radovanovic I. Wälchli T, et al. Among authors: yu k. Nature. 2024 Aug;632(8025):603-613. doi: 10.1038/s41586-024-07493-y. Epub 2024 Jul 10. Nature. 2024. PMID: 38987604 Free PMC article.
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer.
Liu J, Eckert MA, Harada BT, Liu SM, Lu Z, Yu K, Tienda SM, Chryplewicz A, Zhu AC, Yang Y, Huang JT, Chen SM, Xu ZG, Leng XH, Yu XC, Cao J, Zhang Z, Liu J, Lengyel E, He C. Liu J, et al. Among authors: yu k. Nat Cell Biol. 2018 Sep;20(9):1074-1083. doi: 10.1038/s41556-018-0174-4. Epub 2018 Aug 27. Nat Cell Biol. 2018. PMID: 30154548 Free PMC article.
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial.
Liu Y, Zhu XZ, Xiao Y, Wu SY, Zuo WJ, Yu Q, Cao AY, Li JJ, Yu KD, Liu GY, Wu J, Sun T, Cui JW, Lv Z, Li HP, Zhu XY, Jiang YZ, Wang ZH, Shao ZM. Liu Y, et al. Among authors: yu kd. Cell Res. 2023 May;33(5):389-402. doi: 10.1038/s41422-023-00795-2. Epub 2023 Mar 27. Cell Res. 2023. PMID: 36973538 Free PMC article. Clinical Trial.
Challenging transitions.
Wasalathanthri ND, Zaidi SS, Mahrt E, Srivastava S, Yu KH, Johansson KSL, Li F, Jimenez MFT, Lo C, Allareddy V, Romero-Molina C, Mosegaard S, Heaton SM, Park JJ, Bacon CD, Yu S, Polat EO, Wasalathanthri D, Wang W, Agarwal D. Wasalathanthri ND, et al. Among authors: yu kh. Science. 2019 Jan 4;363(6422):24-26. doi: 10.1126/science.aaw2641. Science. 2019. PMID: 30606829 No abstract available.
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation.
O'Reilly EM, Lee JW, Zalupski M, Capanu M, Park J, Golan T, Tahover E, Lowery MA, Chou JF, Sahai V, Brenner R, Kindler HL, Yu KH, Zervoudakis A, Vemuri S, Stadler ZK, Do RKG, Dhani N, Chen AP, Kelsen DP. O'Reilly EM, et al. Among authors: yu kh. J Clin Oncol. 2020 May 1;38(13):1378-1388. doi: 10.1200/JCO.19.02931. Epub 2020 Jan 24. J Clin Oncol. 2020. PMID: 31976786 Free PMC article. Clinical Trial.
9,067 results